Christine Baeder, chief operating officer for generics and biosimilars at Teva USA and newly named chair of the Association for Accessible Medicines, tells this week’s Video Forum about the threats facing the generic pharmaceutical industry and what should be done to counter them.
Christine Baeder, chief operating officer for generics and biosimilars at Teva USA and newly named chair of the Association for Accessible Medicines, tells this week’s Video Forum about the threats facing the generic pharmaceutical industry and what should be done to counter them. She also discusses the relatively slow pace of adoption of biosimilars in the U.S., the impact of innovative payment models on the marketplace, and the value that generics represent.
The FTC faces off against lawyers from Albertsons and Kroger in a fight over competition in the grocery channel.
Moderna's updated COVID-19 vaccine targets the KP.2 variant of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older.
The company argues that by proceeding in its administrative tribunal, in addition to the separate action in federal court, the FTC is violating Constitutional protections.
CRN’s most recent brief argues that the NY AG does not meaningfully address CRN’s arguments about the Act’s constitutional infirmities.
The National Community Pharmacists Association in a statement urged incoming HHS Secretary RFK Jr. to prioritize reforming PBMs and insurers.
"Consumers increasingly opt for over-the-counter brand solutions for earwax removal and maintenance, reflecting a broader trend towards self-care."
A federal judge ruled that a court, not an arbitrator, must decide whether claims against CVS in a class action lawsuit should be arbitrated. The decision challenges CVS's arbitration practices and could have significant implications for future cases.
Sessions included a T2D overview and lifestyle management strategies.
